JPRN-UMIN000051113
Recruiting
Phase 2
Salvage focal therapy for prostate cancer using low-dose-rate brachytherapy - Salvage focal brachytherapy for prostate cancer
Saitama Cancer Center0 sites100 target enrollmentMay 20, 2023
Conditionsprostate cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- prostate cancer
- Sponsor
- Saitama Cancer Center
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with severe comorbidity
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Primary focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000050997Saitama Cancer Center200
Completed
Not Applicable
Focal therapy of localized prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technologyC61Malignant neoplasm of prostateDRKS00007105Klinik für Urologie, Universitätsmedizin Mannheim50
Recruiting
Not Applicable
Focal therapy for locally recurrent prostate cancerprostate cancerJPRN-UMIN000038761Tokyo Medical and Dental University100
Recruiting
Not Applicable
Focal Brachytherapy for localized prostate cancer diagnosed by saturation biopsyJPRN-UMIN000044790ara Medical University35
Recruiting
Phase 1
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 TrialProstate cancerTherapeutic area: Diseases [C] - Neoplasms [C04]CTIS2022-501551-90-00Gasthuiszusters Antwerpen493